There was strong demand in China, especially for infant milk formula and medical nutrition products.
Growth in the Americas and APMEA regions supported Kerry’s first-half performance despite persistent macroeconomic challenges.
Second quarter Adjusted EBITDA loss was $3.6 million, which is an improvement of $7.4 million compared to the prior year period.
Net result rose by 25.7 per cent to 230 million euros (US$269.95 million).
Net profit grew by 1.02% to Rs 27.58 crore.